Contrary to drug efflux, the Replication Factor C Subunit 1 (RFC1 gene), situated on the tumour cell membrane, modulates the accumulation of methotrexate (MTX), a chemotherapeutic agent commonly used in osteosarcomas [9,12,14]. Here, RFC1 is linked to neoplasm.